Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 12/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 3/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22749258 | 0.85 | CTSK (0.54) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL806058 | 0.85 | CTSK (0.54) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL3688912 | 0.83 | CTSK (0.50) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL9906584 | 0.83 | CTSK (0.50) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL963465 | 0.79 | CTSK (0.53) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL327825 | 0.79 | CTSK (0.53) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL2058674 | 0.79 | CTSK (0.53) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL13365447 | 0.76 | CTSK (0.54) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL7148686 | 0.76 | CA1 (0.55) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL1991719 | 0.76 | CA1 (0.51) | CTSKCA1CA2CA7CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3296295-A1 | COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID RELATED DISEASES | American Life Science Pharmaceuticals, Inc. (US) | 2018-03-21 | — | — | EP | disclosed |